Loading news article.

Newsfiscal.ai

Turn Therapeutics' GX-03 Named 'Developmental Immunology Solution of the Year'

Nov 5, 2026, 09:03 ET · Published

Article summary

Turn Therapeutics Inc. announced that its GX-03 therapy has been recognized as the 'Developmental Immunology Solution of the Year' in the 2026 BioTech Breakthrough Awards.

An excerpt from the original article.

Related companies

Turn Therapeutics Inc. Common StockTTRXView stock

Analyzed by WAPE AI.

Preparing English content…

Repost

Comments —

Loading comments…